AttendMe Owl Logo
AttendMe
Evidence Evolution
ENT / Head & Neck SurgeryENT / Head & Neck Surgery

How This Evidence Evolved

Acute Sinusitis Antibiotic Evidence

From routine antibiotics to evidence-based watchful waiting

29.2

Timeline

Signal

Early observations and pilot data that first suggested a new direction

Placebo-controlled trials and systematic reviews question routine antibiotic use for uncomplicated acute rhinosinusitis. A Cochrane review included 15 trials and 3057 adults: without antibiotics, 46% were cured after 1 week and 64% after 14 days. Antibiotics accelerated cure in only 5–11 additional people per 100, while 13 additional people experienced side effects. The review could not establish effects in children, immunosuppressed patients or severe sinusitis because those populations were excluded.
Proof

Landmark RCTs and pivotal trials that established the evidence base

Garbutt randomized 166 adults with uncomplicated acute rhinosinusitis to amoxicillin 1500 mg/d or placebo for 10 days. Symptom scores did not differ significantly at day 3 or day 10. At day 7, improvement favored amoxicillin: 74% versus 56% reported symptom improvement. The mean score difference was 0.19, compared with a minimally important difference of 0.5. Williamson randomized 240 participants aged 16 years or older in a factorial trial of amoxicillin and nasal budesonide. Neither treatment alone or combined was effective for acute sinusitis in primary care.
Extension

Follow-up studies, subgroup analyses, and real-world validation

The Cochrane review included 15 trials involving 3057 participants. Without antibiotics, 46% were cured after 1 week and 64% after 14 days. For clinical diagnosis, antibiotics produced an NNTB of 19 (95% CI 10 to 205); the NNTH for side effects was 8 (95% CI 6 to 12). In a trial selecting patients with CT fluid levels or total opacification, antibiotic cure rates were higher (OR 4.89, 95% CI 1.75 to 13.72; NNTB 4). Imaging findings therefore require context. The review could not establish effects in children, immunosuppressed people, or severe sinusitis because these populations were excluded.
Guidelines

Integration into clinical practice guidelines and recommendations

AAO-HNS 2015 recommends either watchful waiting or initial antibiotics for adults with uncomplicated bacterial rhinosinusitis, with reassessment if worsening occurs or improvement has not occurred by 7 days.
AAO-HNS

Watchful waiting without antibiotics is an acceptable option for uncomplicated acute sinusitis; recommend symptomatic management and reassessment if no improvement after 7 days

IDSA
Now

Current standard of care and ongoing research directions

For uncomplicated acute rhinosinusitis, the Cochrane review found marginal antibiotic benefit alongside adverse effects. This conclusion does not cover severe disease, children or immunosuppressed patients. AAO-HNS allows watchful waiting or antibiotics for uncomplicated adult bacterial rhinosinusitis, with reassessment by 7 days if not improving or earlier if worsening. Symptomatic options include analgesics, intranasal steroids and saline irrigation.

Landmark Trials in This Story

Explore the evidence yourself

Ask AttendMe about any trial, guideline, or clinical question. Evidence-ranked answers from 3.7M+ peer-reviewed articles.

Related Evidence

Frequently Asked Questions

When should antibiotics be prescribed for acute sinusitis?+
For uncomplicated adults, AAO-HNS permits watchful waiting or initial antibiotics, with reassessment if worsening or not improving by 7 days after diagnosis. Severe illness and populations excluded from the trials need separate assessment.
Should a CT scan be obtained for acute sinusitis?+
Do not routinely obtain imaging for patients meeting acute rhinosinusitis criteria unless a complication or alternative diagnosis is suspected. Diagnosis of uncomplicated acute disease is primarily clinical.
What is the recommended symptomatic treatment for acute sinusitis?+
AAO-HNS lists analgesics, topical intranasal steroids and nasal saline irrigation as options for symptomatic relief of viral or bacterial rhinosinusitis.

Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice. Clinical decisions should always be based on individual patient assessment, local guidelines, and professional judgement.

All data sourced from published, peer-reviewed articles and clinical practice guidelines.

Claims checked against cited sources: 10 November 2026